N-Nitroso Clindamycin - Request Quote
N-Nitroso Clindamycin
| SZ CAT No: | SZ-C076087 |
| CAS No | NA |
| Mol.F. | C18H32ClN3O6S |
| Mol.Wt. | 454.0 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
N-Nitroso Clindamycin is chemically (2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-N-nitroso-4-propylpyrrolidine-2-carboxamide. N-Nitroso Clindamycin is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso Clindamycin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clindamycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality N-Nitroso Clindamycin
Purchase N-Nitroso Clindamycin
N-Nitroso Clindamycin suppliers
N-Nitroso Clindamycin manufacturers
N-Nitroso Clindamycin price
Order N-Nitroso Clindamycin
Enquire N-Nitroso Clindamycin
N-Nitroso Clindamycin cost
N-Nitroso Clindamycin Supplier
N-Nitroso Clindamycin Distributor
N-Nitroso Clindamycin for Method Validation
Clindamycin Reference Standard
N-Nitroso Clindamycin for ANDA Filing
N-Nitroso Clindamycin for Forced Degradation Studies
N-Nitroso Clindamycin Identification Standards
N-Nitroso Clindamycin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.